Gilead Sciences (GILD)

Total Non-Current Liabilities

$26.60B

Quarterly · Period ending: · USD

GILD logo

GILD Total Non-Current Liabilities

Latest reported$26.60B
GILD Quarterly Total Non-Current Liabilities ($500.00K → $26.60B)
High-resolution chart · PNG

GILD total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
26,598,000,000
23,372,000,000
24,592,000,000
24,780,000,000
24,941,000,000
25,013,000,000
27,745,000,000
24,411,000,000
24,602,000,000
25,821,000,000
28,096,000,000
28,187,000,000
27,280,000,000
30,410,000,000
30,724,000,000
31,077,000,000
33,435,000,000
34,607,000,000
35,278,000,000
35,382,000,000
38,060,000,000
38,823,000,000
38,789,000,000
33,898,000,000
27,228,000,000
28,683,000,000
29,218,000,000
28,843,000,000
31,498,000,000
31,349,000,000
31,536,000,000
31,182,000,000
32,709,000,000
34,060,000,000
38,147,000,000
29,811,000,000
28,680,000,000
28,502,000,000
28,396,000,000
28,176,000,000
23,421,000,000
22,836,000,000
22,713,000,000
23,333,000,000
13,608,000,000
13,305,000,000
13,084,000,000
8,925,831,000
8,548,825,000
8,460,722,000
4,427,000,000
6,380,831,000
6,343,852,000
7,528,980,000
7,458,219,000
7,411,519,000
7,431,889,000
8,398,398,000
7,920,995,000
4,182,261,000
4,171,968,000
4,043,228,000
3,005,843,000
2,986,711,000
690,985,000
1,305,675,000
1,321,770,000
1,295,574,000
1,295,241,000
1,240,834,000
1,250,256,000
1,421,448,000
200,763,000
1,500,505,000
1,498,152,000
1,482,691,000
1,473,312,000
1,464,325,000
1,452,896,000
1,418,473,000
1,473,766,000
216,169,000
273,375,000
33,954,000
34,893,000
35,797,000
31,637,000
372,878,000
366,475,000
367,636,000
365,853,000
616,407,000
611,267,000
611,576,000
611,950,000
267,922,000
257,244,000
261,711,000
262,232,000
263,052,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.